GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Nearly three-quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.